Home Cart Sign in  
Chemical Structure| 25526-93-6 Chemical Structure| 25526-93-6

Structure of Alovudine
CAS No.: 25526-93-6

Chemical Structure| 25526-93-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

3'-Fluoro-3'-deoxythymidine (Alovudine) is a DNA synthesis marker that is less sensitive to inflammatory changes, making it more effective as a biomarker in pancreatic cancer. It also has anti-acne activity.

Synonyms: 3'-Fluoro-3'-deoxythymidine; 3′-Deoxy-3′-fluorothymidine; NSC 140025

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Alovudine

CAS No. :25526-93-6
Formula : C10H13FN2O4
M.W : 244.22
SMILES Code : OC[C@@H]1[C@@H](F)C[C@H](N2C(NC(C(C)=C2)=O)=O)O1
Synonyms :
3'-Fluoro-3'-deoxythymidine; 3′-Deoxy-3′-fluorothymidine; NSC 140025
MDL No. :MFCD00056058
InChI Key :UXCAQJAQSWSNPQ-XLPZGREQSA-N
Pubchem ID :33039

Safety of Alovudine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Related Pathways of Alovudine

DNA

Isoform Comparison

Biological Activity

Description
Alovudine (3'-Fluoro-3'-deoxythymidine) serves as a marker of DNA synthesis and is less affected by inflammatory changes than 18F-Fluorodeoxyglucose (FDG), making it a more suitable biomarker for pancreatic cancer. Additionally, alovudine exhibits activity against orthopoxviruses[1].[2].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00002254 HIV Infections COMPLETED - Johns Hopkins Hosp, Baltimore,... More >> Maryland, 21287, United States|Mem Sloan - Kettering Cancer Ctr, New York, New York, 10021, United States|Univ of North Carolina School of Medicine, Chapel Hill, North Carolina, 275997215, United States Less <<
NCT00002260 HIV Infections COMPLETED - Johns Hopkins Hosp, Baltimore,... More >> Maryland, 21205, United States Less <<
NCT03633955 Acute Lymphocytic Leukemia|Acu... More >>te Myeloid Leukemia|Ambiguous Lineage Leukemia or Lymphoma|Myeloma Less << PHASE1 RECRUITING 2025-04-27 Children's National Health Sys... More >>tem, Washington, District of Columbia, 20010, United States|Emory University, Atlanta, Georgia, 30322, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73117, United States Less <<
NCT00002271 HIV Infections COMPLETED - Johns Hopkins Hosp, Baltimore,... More >> Maryland, 21205, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.09mL

0.82mL

0.41mL

20.47mL

4.09mL

2.05mL

40.95mL

8.19mL

4.09mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories